Skip to main navigation

Skip to Content

Menu

About Cerevel
Our Programs
- Tavapadon
- CVL-871
- CVL-865
- CVL-231
- CVL-936
Our Science
- Our scientific strategy
- Our pipeline
Investor & Media
Careers
- Working at Cerevel Therapeutics
- Open positions
Contact Us

Quarterly Results

Quarterly Results

Show all

2020

Q3

Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights
Form 10-Q

Print

RSS Feeds

Email Alerts

Investor Contact

Search

Cerevel

About CerevelAbout Cerevel
Our ProgramsOur Programs
- Tavapadon
- CVL-871
- CVL-865
- CVL-231
- CVL-936
Our ScienceOur Science
- Our scientific strategy
- Our pipeline
NewsroomNewsroom
CareersCareers
- Working at Cerevel Therapeutics
- Open Positions
Contact Us

Facebook
Twitter
LinkedIn
YouTube

Cerevel

Terms of Use
Privacy Policy

© 2021 Cerevel Therapeutics

CEREVEL and the CEREVEL logo are trademarks of

Cerevel Therapeutics. All Rights Reserved.